retatrutide patches RetaPatch™ GLP-1 Patches': Are They Too

They can also evaluate other medication options for treating your condition

Novo also reported in early 2026 that CagriSema showed superior HbA1c reduction and weight loss vs semaglutide in a Phase 3 diabetes program (REIMAGINE 2)

Where SB 860 is now: a timeline December 10, 2025 Bill filed SB 860 is formally introduced in the Florida Senate

[13] [14] Scientific References Ozempic 0.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (emc product 9750)

[DOI] [PMC free article] [PubMed] [Google Scholar] 69.FDA Approves Weight Management Drug for Patients Aged 12 and Older FDA

evaluated retatrutide a once-weekly injectable agent targeting GLP-1, GIP, and glucagon receptors simultaneously across multiple doses in adults with obesity or overweight without type 2 diabetes